BlackRock »

Vir Biotechnology shares owned by BlackRock

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $123M 16M 7.49

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Vir Biotechnology

BlackRock
BlackRock
Vanguard Group
State Street Corporation
OrbiMed Advisors
Baillie Gifford & Co
Geode Capital Management
Morgan Stanley
Bill & Melinda Gates Foundation
Dimensional Fund Advisors
Renaissance Technologies
Charles Schwab Investment Management
Jpmorgan Chase & Co
Voloridge Investment Management
D. E. Shaw & Co

View all funds holding Vir Biotechnology